1.
Electrocardiographic profiles from 24-hour monitoring of COVID-19 patients treated with hydroxychloroquine and azithromycin. Rev. Fed. Arg. Cardiol. [Internet]. 2021 Jun. 29 [cited 2026 Oct. 5];50(1):21-6. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/135